Skip to content

Multi-center research for standardized diagnosis of liver fibrosis with high-tech MR and artificial intelligence

Multi-center research for standardized diagnosis of liver fibrosis with high-tech MR and artificial intelligence

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900026994
Enrollment
Unknown
Registered
2019-10-28
Start date
2019-11-30
Completion date
Unknown
Last updated
2019-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver fibrosis

Interventions

Sponsors

Shanghai Public Health Clinical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with clinically confirmed chronic hepatitis B, the diagnosis of chronic hepatitis B conforms to the diagnostic criteria issued by the European Association for the study of liver diseases in 2017; 2. Liver fibrosis is confirmed by hepatectomy or biopsy within three months; 3. Aged > 18 years; 4. Sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Combined with other viral hepatitis; 2. Child Pugh score >=7 points; 3. Received anti-virus and anti fibrosis treatment before MR examination; 4. Ddiffuse liver occupation; 5. History of liver surgery or interventional treatment; 6. Difficulty in respiratory movement coordination; 7. With contraindications for enhanced MRI (such as incompatible devices, claustrophobia, severe renal insufficiency, etc.).

Design outcomes

Primary

MeasureTime frame
?T110 min%;

Countries

China

Contacts

Public ContactYuxin Shi

Shanghai Public Health Clinical Center

shiyx828288@163.com+86 18930810066

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026